A theory of natural addiction

Games and Economic Behavior

Volumn 59, Issue 2, 2007, Pages 316-344

  Smith, Trenton G ^a   Tasnádi, Attila ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b Institute of Entrepreneurship and Innovation   (Hungary)

Author keywords

Behavioral ecology; Endogenous opioids; Neuroendocrinology; Sugar addiction

Indexed keywords

EID: 34248578411     PISSN: 08998256     EISSN: 10902473     Source Type: Journal    
DOI: 10.1016/j.geb.2006.08.006     Document Type: Article

References (106)

1. Ainslie G. Derivation of rational economic behavior from hyperbolic discount curves. Amer. Econ. Rev. 81 2 (1991) 334-340
2. Atkinson R. Naloxone decreases food intake in obese humans. J. Clinical Endocrinology Metabolism 55 (1982) 196-198
3. Baldwin B., and Parrot R. Effects of intracerebroventricular injection of naloxone on operant feeding and drinking in pigs. Pharmacol. Biochem. Behav. 22 (1985) 37-40
4. Baron-Cohen S. Mindblindness: An Essay on Autism and Theory of Mind (1995), MIT Press, Cambridge, MA
5. Becker G.S., and Murphy K.M. A theory of rational addiction. J. Polit. Economy 96 4 (1988) 675-700
6. Becker G.S., Grossman M., and Murphy K.M. An empirical analysis of cigarette addiction. Amer. Econ. Rev. 84 (1994) 396-418
7. Bergstrom T. Economics in a family way. J. Econ. Lit. 34 4 (1996) 1903-1934
8. Bernheim, B.D., Rangel, A., 2002. Addiction and cue conditioned cognitive processes. Working paper w9329. NBER
9. Blass E. Functional interaction between the positive effect of sweet and the negative effect of pain and distress. Appetite 7 (1986) 243
10. Blass E., and Hoffmeyer L. Sucrose as an analgesic for newborn infants. Pediatrics 87 (1991) 215-218
11. Blass E., Fitzgerald E., and Kehoe P. Interactions between sucrose, pain and isolation distress. Pharmacol. Biochem. Behav. 26 (1987) 483-489
12. Bodnar R.J., and Hadjimarkou M.M. Endogenous opiates and behavior: 2001. Peptides 23 (2002) 2307-2365
13. Booth M. Opium: A History (1996), Simon & Schuster, London
14. Brick J., and Erickson C. Drugs, the Brain, and Behavior: The Pharmacology of Abuse and Dependence (1998), Haworth Medical Press, Binghamton, New York
15. Camerer C., Issacharoff S., Loewenstein G., O'Donoghue T., and Rabin M. Regulation for conservatives: Behavioral economics and the case for asymmetric paternalism. Univ. Pennsylvania Law Rev. 151 (2003) 1211-1254
16. Camerer C., Loewenstein G., and Prelec D. Neuroeconomics: How neuroscience can inform economics. J. Econ. Lit. 43 1 (2005) 9-64
17. Campbell M., Adams P., Small A., Yesch L., and Curren E. Naltrexone in infantile autism. Psychopharmacol. Bull. 24 (1988) 135-139
18. Carson-DeWitt R. Encyclopedia of Drugs, Alcohol, and Addictive Behavior. second ed (2001), Macmillan Reference USA, New York
19. Chiara G.D. Drug addiction as a dopamine-dependent associative learning disorder. Europ. J. Pharmacol. 375 (1999) 13-30
20. Cohen M., Cohen R., Pickar D., and Murphy L. Naloxone reduces food intake in humans. Psychosomatic Medicine 47 (1985) 132-138
21. Colantuoni C., Rada P., McCarthy J., Patten C., Avena N.M., Chadeayne A., and Hoebel B.G. Evidence that intermittent, excessive sugar intake causes endogenous opioid dependence. Obesity Res. 10 (2002) 478-488
22. Cooper S., and Higgs S. Neuropharmacology of appetite and taste preferences. In: Legg C., and Booth D. (Eds). Appetite, Neural and Behavioral Bases (1994), Oxford Univ. Press, New York 212-242
23. Cooper J.R., Bloom F.E., and Roth R.H. The Biochemical Basis of Neuropharmacology. eighth ed (2002), Oxford Univ. Press
24. Cummings D.E., and Schwartz M.W. Genetics and pathophysiology of human obesity. Annual Rev. Medicine 54 (2003) 453-471
25. Deth R.C. Molecular Origins of Human Attention: The Dopamine-Folate Connection (2003), Kluwer Academic, Boston
26. Drewnowski A., Krahn D., Demitrack M., Nairn K., and Gosnell B. Taste responses and preferences for sweet high-fat foods: Evidence for opioid involvement. Physiol. Behav. 51 (1992) 371-379
27. Dudley R. Evolutionary origins of human alcoholism in primate frugivory. Quart. Rev. Biol. 75 1 (2000) 315
28. Dum J., Gramsch C., and Herz A. Activation of hypothalamic beta-endorphin pools by reward induced by highly palatable food. Pharmacol. Biochem. Behav. 18 (1983) 443-447
29. Fantino M., Hosotte J., and Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Amer. J. Physiol. 252 (1986) R91-R96
30. Fehr E., and Zych P.K. Do addicts behave rationally?. Scand. J. Econ. 100 3 (1998) 643-662
31. Foster J., Morrison M., Dean S., Hill M., and Frenk H. Naloxone suppresses food/water consumption in the deprived cat. Pharmacol. Biochem. Behav. 14 (1981) 419-421
32. Gillberg C.L.T., and Lonnerholm G. Endorphin activity in childhood psychosis. Archives General Psychiatry 42 (1985) 780-783
33. Gilbertson T., and Kim I. 'Chemoreception of fat,' chemistry of taste: Mechanisms, behaviors, and mimics. ACS Symp. Ser. 825 (2002) 180-191
34. Gosnell B., and Levine A. Stimulation of ingestive behavior by preferential and selective opioid agonists. In: Cooper S., and Clifton P. (Eds). Drug Receptor Subtypes and Ingestive Behaviour (1996), Academic Press, San Diego 147-166
35. Griffiths R., and Balster R. Opioids: Similarity between evaluations of subjective effects and animal self-administration results. Clinical Pharmacol. Therapeutics 25 (1979) 611-617
36. Grossman M., Chaloupka F.J., and Sirtalan I. An empirical analysis of alcohol addiction: Results from monitoring the future panels. Econ. Inquiry 36 1 (1998) 39-48
37. Gruber J., and Köszegi B. Is addiction rational? Theory and evidence. Quart. J. Econ. 116 4 (2001) 1261-1303
38. Gul F., and Pesendorfer W. Temptation and self-control. Econometrica 69 6 (2001) 1403-1435
39. Harrigan S., and Downs D. Continuous intravenous naltrexone effects on morphine self-administration in rhesus monkeys. J. Pharmacol. Exper. Therapeutics 204 (1978) 481-486
40. Headlee C., Coppock H., and Nichols J. Apparatus and technique involved in a laboratory method of detecting the addictiveness of drugs. J. Amer. Pharmaceutical Assoc. 44 (1955) 229-231
41. Hirshleifer J. Economics from a biological viewpoint. J. Law Econ. 20 (1977) 1-52
42. Hirshleifer J. The expanding domain of economics. Amer. Econ. Rev. 75 6 (1985) 53-68
43. Holtzman S. Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J. Pharmacol. Exper. Therapy 189 (1974) 51-60
44. Jaffe J., and Martin W. Opioid analgesics and antagonists. In: Gillmina A., Rall T., Nies A., and Taylor P. (Eds). The Pharmacological Basis of Therapeutics (1990), Pergamon Press, New York 485-521
45. Kahneman D., Wakker P.P., and Sarin R. Back to Bentham? Explorations of experienced utility. Quart. J. Econ. 112 2 (1997) 375-405
46. Kalat J.W. Letter to the editor: Speculations on similarities between autism and opiate addiction. J. Autism Childhood Schizophrenia 8 4 (1978) 477-479
47. Kavaliers M., Hirst M., and Teskey G. Opioid systems and feeding in the slug: Similarities to and implications for mammalian feeding. Brain Res. Bull. 14 (1985) 681-685
48. Kavaliers M., Guglick M., and Hirst M. Opioid involvement in the control of feeding of an insect, the American cockroach. Life Sci. 49 (1987) 665-672
49. Killian A., Bonese K., and Schuster C. The effects of naloxone on behavior maintained by cocaine and heroin injections in the rhesus monkey. Drug Alcohol Depend. 3 (1978) 243-251
50. Laibson D. Golden eggs and hyperbolic discounting. Quart. J. Econ. 112 2 (1997) 443-477
51. Laibson D. A cue-theory of consumption. Quart. J. Econ. 116 1 (2001) 81-119
52. Leboyer M., Bouvard M., and Dugas M. Effects of naltrexone on infantile autism. Lancet 1 (1988) 715
53. Leboyer M., Bouvard M., Lensing P., and Launay J. Opioid excess hypothesis of autism: A double-blind study of naltrexone. Brain Dysfunction 3 (1990) 285-298
54. Loewenstein G. Out of control: Visceral influences on behavior. Organ. Behav. Human Dec. Processes 65 3 (1996) 272-292
55. Martin W., Wickler C., Eades C., and Pescor F. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4 (1963) 247-260
56. McKim W.A. Drugs and Behavior: An Introduction to Behavioral Pharmacology. fifth ed (2002), Prentice Hall
57. Mello N.K., and Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14 6 (1996) 357-424
58. Mercer M.E., and Holder M.D. Food cravings, endogenous opioid peptides, and food intake: A review. Appetite 29 (1997) 325-352
59. Morley J., Parker S., and Levine A. The effect of butorphanol tartrate on food and water consumption in humans. Amer. J. Clinical Nutrition 42 (1985) 1175-1178
60. Mucha R., and Iversen S. Reinforcing properties of morphine and naloxone revealed by conditioned place preferences: A procedural examination. Psychopharmacology 82 (1984) 241-247
61. Mucha R.F., van der Kooy D., O'Shaughnessy M., and Bucenieks P. Drug reinforcement studied by the use of place conditioning in rat. Brain Res. 243 (1982) 91-105
62. National Institute on Drug Abuse, 2000. Heroin: Abuse and addiction, Research report series, NIDA
63. Nelson R.J. An Introduction to Behavioral Endocrinology. second ed (2000), Sinauer, Sunderland, MA
64. Nesse R. An evolutionary perspective on substance abuse. Ethol. Sociobiol. 15 (1994) 339-348
65. Nesse R.M., and Berridge K.C. Psychoactive drug use in evolutionary perspective. Science 278 (1997) 63-66
66. O'Donoghue, T., Rabin, M., 2002. Addiction and present-biased preferences. Mimeo
67. Orphanides A., and Zervos D. Rational addiction with learning and regret. J. Polit. Economy 103 4 (1995) 739-758
68. Orphanides A., and Zervos D. Myopia and addictive behaviour. Econ. J. 108 (1998) 75-91
69. Ostrowski N., Rowland N., Foley T., Nelson T., and Reid L. Morphine antagonists and consummatory behavior. Pharmacol. Biochem. Behav. 14 (1981) 549-559
70. Parfitt K. Martindale: The Complete Drug Reference. thirty-second ed (1999), Pharmaceutical Press, Taunton, MA
71. Pert C.B., and Snyder S.H. Opiate receptor: Demonstration in nervous tissue. Science 179 (1973) 1011-1014
72. Pomerleau C.S. Co-factors for smoking and evolutionary psychobiology. Addiction 92 4 (1997) 397-408
73. Raiten D.J., and Massaro T. Perspectives on the nutritional ecology of autistic children. J. Autism Developmental Disorders 16 2 (1986) 133-142
74. Raven P.H., Evert R.F., and Eichhorn S.E. Biology of Plants. sixth ed (1999), Freeman, New York
75. Robson A.J. The biological basis of economic behavior. J. Econ. Lit. 39 1 (2001) 11-33
76. Rogers A.R. Evolution of time preference by natural selection. Amer. Econ. Rev. 84 3 (1994) 460-481
77. Rudski J., Grace M., Billington C., and Levine A. Increased food intake following morphine or MPT administration into the ventral tegmental area of rats. Soc. Neurosci. Abstracts 18 (1992) 1427
78. Samuelson L. Information-based relative consumption effects. Econometrica 72 (2004) 93-118
79. Sanger D., McCarthy P., Lord J., and Smith C. The anorectic properties of opiate antagonists. Drugs Devel. Res. 3 (1983) 137-142
80. Savage L.J. The Foundations of Statistics (1954), Wiley
81. Schuckit M.A. New findings in the genetics of alcoholism. J. Amer. Medical Assoc. 281 20 (1999) 1875-1876
82. Si E., Bryant H., and Yim G. Opioid and non-opioid components of insulin-induced feeding. Pharmacol. Biochem. Behav. 24 (1986) 899-903
83. 3H]-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. 70 (1973) 1947-1949
84. Simpkins J., Michel M., and Tuttle R. Effects of the narcotic antagonist, nalmefene, on spontaneous and insulin-induced food intake and body weight gain in male rats. Soc. Neurosci. Abstr. 11 (1985) 59
85. Smith, T.G., 2002. Toward a unified theory of choice: Case studies in dietary preference. Doctoral thesis. University of California, Santa Barbara
86. Smith T.G. The McDonald's equilibrium: Advertising, empty calories, and the endogenous determination of dietary preferences. Soc. Choice Welfare 23 3 (2004) 383-413
87. Sozou P. On hyperbolic discounting and uncertain hazard rates. Proc. R. Soc. Lond. Ser. B: Biol. Sci. 265 1409 (1998) 2015-2020
88. Spanagel R., and Weiss F. The dopamine hypothesis of reward: Past and current status. Trends Neurosci. 22 11 (1999) 521-527
89. Sullivan R., and Hagen E. Psychotropic substance-seeking: Evolutionary pathology or adaptation?. Addiction 97 (2002) 389-400
90. Sullivan S.L. Mammalian chemosensory receptors. NeuroReport 13 1 (2002) A9-A17
91. ter Riet G., de Craen A.J., de Boer A., and Kessels A.G. Is placebo analgesia mediated by endogenous opioids? A systematic review. Pain 76 (1998) 273-275
92. Terenius L. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharmacologica et Toxicologica 32 (1974) 317-319
93. US Department of Health and Human Services, 1989. Reducing the health consequences of smoking: 25 years of progress. A report of the surgeon general, Publication No. 89-8411, DHHS, CDC
94. van Ree J.M., Wied D.D., Bradbury A., Hume E., Smyth D., and Snell C. Induction of tolerance to the analgesic action of lipotropin C-fragment. Nature 264 (1976) 792-794
95. van Ree J.M., Gerrits M.A., and Vanderschuren L.J. Opioids, reward, and addiction: An encounter of biology, psychology, and medicine. Pharmacol. Rev. 51 2 (1999) 341-396
96. van Ree J.M., Niesink R.J., van Wolfswinkel L., Ramsey N.F., Kornet M.L.M., van Furth W.R., Vanderschuren L.J., Gerrits M.A., and van den Berg C.L. Endogenous opioids and reward. Europ. J. Pharmacol. 405 (2000) 89-101
97. Waeltl P., Dickinson A., and Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature 412 (2001) 43-48
98. Weeks J. Experimental morphine addiction: Method for automatic intravenous injection in unrestrained rats. Science 138 (1962) 143-144
99. Weeks J., and Collins R. Changes in morphine self-administration in rats induced by prostaglandin E1 and naloxone. Prostaglandins 12 (1976) 11-19
100. Weiss G. Food fantasies of incarcerated drug users. Int. J. Addictions 17 (1982) 905-912
101. Williams G.C., and Nesse R.M. The dawn of Darwinian medicine. Quart. Rev. Biol. 66 1 (1991) 1-22
102. Yamamoto T., Sako N., and Maeda S. Effects of taste stimulation on beta-endorphin levels in rat cerebrospinal fluid and plasma. Physiol. Behav. 69 (2000) 345-350
103. Yeomans M.R., and Gray R.W. Selective effects of naltrexone on food pleasantness and intake. Physiol. Behav. 60 2 (1996) 439-446
104. Yeomans M.R., and Gray R.W. Opioid peptides and the control of human ingestive behavior. Neurosci. Biobehav. Rev. 26 (2002) 713-728
105. Yeomans M.R., and Wright P. Lower pleasantness of palatable foods in nalmefene-treated human volunteers. Appetite 16 (1991) 249-259
106. Zigmond M.J., Bloom F.E., Landis S.C., Roberts J.L., and Squire L.R. Fundamental Neuroscience (1999), Academic Press, San Diego